Sage Therapeutics Ownership | Who Owns Sage Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Sage Therapeutics Ownership Summary


Sage Therapeutics is owned by 84.15% institutional investors, 11.92% insiders, and 3.93% retail investors. Vanguard group is the largest institutional shareholder, holding 10.67% of SAGE shares. BB Biotech AG Ord is the top mutual fund, with 7.31% of its assets in Sage Therapeutics shares.

SAGE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSage Therapeutics84.15%11.92%3.93%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group6.42M10.67%$69.68M
Fmr5.82M9.68%$63.24M
Rtw investments, lp5.48M9.11%$59.52M
Blackrock5.22M8.67%$56.64M
Bellevue group4.46M7.42%$48.49M
State street2.47M4.12%$26.88M
Jacobs levy equity management1.43M2.37%$15.48M
Morgan stanley1.39M2.31%$15.10M
Geode capital management1.24M2.06%$13.46M
Jpmorgan chase1.20M2.00%$13.03M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Palo alto investors lp1.01M1.27%$10.98M
Rtw investments, lp5.48M0.92%$59.52M
Bellevue group4.46M0.79%$48.49M
683 capital management500.00K0.41%$5.43M
Dafna capital management116.20K0.30%$1.26M
Pdt partners233.64K0.24%$2.54M
Values first advisors28.96K0.19%$314.53K
Corton capital26.84K0.15%$291.49K
Virtus etf advisers28.64K0.15%$311.02K
Easterly investment partners136.60K0.13%$1.48M

Top Buyers

HolderShares% AssetsChange
Jacobs levy equity management1.43M0.06%870.16K
Federated hermes670.47K0.02%670.47K
Vanguard group6.42M0.00%664.95K
Invesco661.12K0.00%575.58K
Renaissance553.40K0.01%518.30K

Top Sellers

HolderShares% AssetsChange
Wellington management group llp39.65K0.00%-4.71M
State street2.47M0.00%-2.02M
Deutsche bank ag\26.90K0.00%-1.00M
Samlyn capital---594.66K
Dimensional fund advisors lp509.36K0.00%-416.22K

New Positions

HolderShares% AssetsChangeValue
Boothbay fund management473.50K0.12%473.50K$5.14M
Public employees retirement system of ohio52.28K0.00%52.28K$567.82K
Graham capital management49.37K0.01%49.37K$536.12K
D. e. shaw46.10K0.00%46.10K$500.65K
Thrivent financial for lutherans35.75K0.00%35.75K$389.00K

Sold Out

HolderChange
Dinuzzo private wealth-5.00
Principal securities-6.00
Sjs investment consulting-8.00
Jfs wealth advisors-8.00
Nelson, van denburg & campbell wealth management group-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024185-8.87%51,430,442-3.85%841.06%81-25.69%51-3.77%
Jun 30, 2024200-5.21%53,449,131-8.16%880.94%1069.28%53-8.62%
Mar 31, 2024211-1.40%58,196,5443.77%971.11%9710.23%58-23.68%
Dec 31, 20232141.90%56,081,766-4.03%930.98%88-24.14%7665.22%
Sep 30, 2023210-12.50%58,434,3738.09%971.19%11616.00%46-40.26%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
BB Biotech AG Ord4.46M7.31%-
Fidelity Growth Compy Commingled Pl S2.40M3.93%13.00K
Fidelity Growth Compy Commingled Pl O2.39M3.91%-
Vanguard Total Stock Mkt Idx Inv1.71M2.80%-
SPDR® S&P Biotech ETF1.64M2.69%18.18K
Fidelity Growth Company Fund1.60M2.62%-3.40K
iShares Russell 2000 ETF1.39M2.28%-3.14K
Merchfondo FI950.00K1.55%75.00K
Vanguard Institutional Extnd Mkt Idx Tr837.73K1.37%-3.61K
Vanguard Small Cap Index689.95K1.13%1.35K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 09, 2023Barrett Elizabeth-Buy$37.28K
May 09, 2023Barrett Elizabeth-Buy$50.50K
Feb 10, 2023JONAS JEFFREY M-Sell$347.08K
Feb 10, 2023JONAS JEFFREY M-Sell$172.33K
Nov 10, 2022Greene Barry E President and CEOBuy$500.02K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4--

SAGE Ownership FAQ


Who Owns Sage Therapeutics?

Sage Therapeutics shareholders are primarily institutional investors at 84.15%, followed by 11.92% insiders and 3.93% retail investors. The average institutional ownership in Sage Therapeutics's industry, Biotech Stocks , is 47.04%, which Sage Therapeutics exceeds.

Who owns the most shares of Sage Therapeutics?

Sage Therapeutics’s largest shareholders are Vanguard group (6.42M shares, 10.67%), Fmr (5.82M shares, 9.68%), and Rtw investments, lp (5.48M shares, 9.11%). Together, they hold 29.47% of Sage Therapeutics’s total shares outstanding.

Does Blackrock own Sage Therapeutics?

Yes, BlackRock owns 8.67% of Sage Therapeutics, totaling 5.22M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 56.64M$. In the last quarter, BlackRock increased its holdings by 323.43K shares, a 6.61% change.

Who is Sage Therapeutics’s biggest shareholder by percentage of total assets invested?

Palo alto investors lp is Sage Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.27% of its assets in 1.01M Sage Therapeutics shares, valued at 10.98M$.

Who is the top mutual fund holder of Sage Therapeutics shares?

BB Biotech AG Ord is the top mutual fund holder of Sage Therapeutics shares, with 7.31% of its total shares outstanding invested in 4.46M Sage Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools